0001209191-22-018225.txt : 20220311
0001209191-22-018225.hdr.sgml : 20220311
20220311171830
ACCESSION NUMBER: 0001209191-22-018225
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220119
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Curran Terrie
CENTRAL INDEX KEY: 0001690298
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 22734093
MAIL ADDRESS:
STREET 1: C/O MYOVANT SCIENCES INC.
STREET 2: 320 WEST 37TH STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (877) 742-8466
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-01-19
2022-01-21
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001690298
Curran Terrie
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102
FLORHAM PARK
NJ
07932
1
1
0
0
President and Chief Executive
Common Stock
42955
D
Common Stock
724.1
I
by 401(k)
On January 21, 2022, the Reporting Person filed a Form 4 (the "Original Form 4") which inadvertently reported incorrect amounts of securities beneficially owned following the transactions reported. Following the transactions reported in the Original Form 4, the Reporting Person (i) directly owns 42,955 shares of Common Stock, which includes 41,250 restricted stock units, and (ii) indirectly owns 724.10 shares of Common Stock through a 401(k) account.
/s/ Larry Miller, Attorney-in-Fact for Terrie Curran
2022-03-11